| scholarly article | Q13442814 |
| P50 | author | Moustafa Algamal | Q88745891 |
| P2093 | author name string | James E Evans | |
| Benoit Mouzon | |||
| Fiona Crawford | |||
| Michael Mullan | |||
| Laila Abdullah | |||
| Joseph O Ojo | |||
| Paige Leary | |||
| P2860 | cites work | Ultrastructural Changes in the White and Gray Matter of Mice at Chronic Time Points After Repeated Concussive Head Injury. | Q50709836 |
| Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. | Q51949735 | ||
| Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. | Q52173404 | ||
| Severe head injury hastens age of onset of Alzheimer's disease. | Q53189242 | ||
| Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. | Q53303473 | ||
| Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer's disease. | Q53314166 | ||
| Myo-inositol transport through the blood-brain barrier. | Q55060546 | ||
| Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group | Q67903226 | ||
| Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study | Q80108585 | ||
| Lipidomics: new tools and applications | Q82822475 | ||
| The spectrum of disease in chronic traumatic encephalopathy | Q22242925 | ||
| Neurodegenerative causes of death among retired National Football League players | Q23912768 | ||
| Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse | Q23917574 | ||
| Omega-3 fatty acids: potential role in the management of early Alzheimer's disease | Q24595490 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia | Q26826813 | ||
| Role of oleic acid in immune system; mechanism of action; a review | Q26998929 | ||
| Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes | Q28273275 | ||
| Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model | Q28302146 | ||
| Evidence for a membrane defect in Alzheimer disease brain | Q28343061 | ||
| Chronic neuropathologies of single and repetitive TBI: substrates of dementia? | Q28384302 | ||
| MALDI mass spectrometric imaging of lipids in rat brain injury models | Q28385802 | ||
| APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease. | Q33563660 | ||
| Deregulation of sphingolipid metabolism in Alzheimer's disease | Q33693061 | ||
| Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment | Q33934660 | ||
| Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry | Q33947437 | ||
| Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease | Q33967270 | ||
| Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study | Q33986680 | ||
| Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model | Q34123859 | ||
| Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model | Q34126335 | ||
| Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes | Q34452028 | ||
| The ether lipid-deficient mouse: tracking down plasmalogen functions | Q34572093 | ||
| Phosphatidylserine in the brain: metabolism and function | Q34647336 | ||
| Astrocyte-synthesized oleic acid behaves as a neurotrophic factor for neurons | Q35006320 | ||
| Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. | Q35156240 | ||
| Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex | Q35218379 | ||
| DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease | Q35438097 | ||
| Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet | Q35866844 | ||
| Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers | Q36590043 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| Resolvins and protectins in the termination program of acute inflammation | Q36751363 | ||
| Alzheimer's disease after remote head injury: an incidence study | Q36901829 | ||
| Role of Lipids in Brain Injury and Diseases | Q37051065 | ||
| Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study | Q37105436 | ||
| ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain | Q37379675 | ||
| Depletion of brain docosahexaenoic acid impairs recovery from traumatic brain injury | Q37520738 | ||
| Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk | Q37629069 | ||
| Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk | Q37739669 | ||
| Saturated and trans fats and dementia: a systematic review | Q38219298 | ||
| Polyunsaturated fatty acids and their metabolites in brain function and disease. | Q38267176 | ||
| Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury | Q39474261 | ||
| Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms | Q39591498 | ||
| Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? | Q41114300 | ||
| Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. | Q42484560 | ||
| Differences in CSF phospholipid concentration by traumatic brain injury outcome | Q43118342 | ||
| Brain membrane phospholipid alterations in Alzheimer's disease | Q43743686 | ||
| Dietary intake of antioxidants and risk of Alzheimer disease | Q44036285 | ||
| Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease | Q44536587 | ||
| Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury | Q44567404 | ||
| Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. | Q44578995 | ||
| Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. | Q44937300 | ||
| Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients | Q45090933 | ||
| Chronic elevation of phosphocholine containing lipids in mice exposed to Gulf War agents pyridostigmine bromide and permethrin | Q45176401 | ||
| Midlife cardiovascular risk factors and risk of dementia in late life | Q45236740 | ||
| Lipidomic analyses identify injury-specific phospholipid changes 3 mo after traumatic brain injury. | Q46840557 | ||
| Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice | Q47403984 | ||
| Lifelong behavioral and neuropathological consequences of repetitive mild traumatic brain injury. | Q47644244 | ||
| Lipidomic profiling of phosphocholine-containing brain lipids in mice with sensorimotor deficits and anxiety-like features after exposure to Gulf War agents | Q47974323 | ||
| Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia | Q48090023 | ||
| Fatty acid transport through the blood-brain barrier | Q48117653 | ||
| The potential for DHA to mitigate mild traumatic brain injury | Q48180488 | ||
| Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study | Q48351467 | ||
| Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study | Q48371548 | ||
| Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta. | Q48423106 | ||
| Regional membrane phospholipid alterations in Alzheimer's disease. | Q48524004 | ||
| Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. | Q48557430 | ||
| Delayed phospholipid degradation in rat brain after traumatic brain injury. | Q48677332 | ||
| Small changes of dietary (n-6) and (n-3)/fatty acid content ration alter phosphatidylethanolamine and phosphatidylcholine fatty acid composition during development of neuronal and glial cells in rats. | Q48716289 | ||
| Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. | Q49160284 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| omega-3 fatty acid | Q191756 | ||
| sphingomyelin | Q423143 | ||
| omega-6 fatty acid | Q306246 | ||
| P304 | page(s) | 103 | |
| P577 | publication date | 2019-02-19 | |
| P1433 | published in | Frontiers in Neuroscience | Q2177807 |
| P1476 | title | Converging and Differential Brain Phospholipid Dysregulation in the Pathogenesis of Repetitive Mild Traumatic Brain Injury and Alzheimer's Disease | |
| P478 | volume | 13 |
| Q97521140 | Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia | cites work | P2860 |
Search more.